MARATTO

article · Epidemiology and Public Health

Malaria and Cervical Cancer Risk from HPV in Kampala, Uganda

20241 citationOpen accessGulu University

Abstract

When it was clear that the Burkitt’s-Lymphoma, prototype for many African tumours, was attributable to an oncogenic virus, the EBV, and to Falciparum Malaria (FM), [1-5] an extension of these findings was mandatory. Many years back in an epidemiological study assessing human papilloma viruses we postulated therefore that cosmopolitan malaria is a causal factor in cancer of the uterine cervix (CC) [6]. Supported generously by Karolinska Institutet in Stockholm, the ugandan counterpart in our study group worked extensively on HIV and, as others, found no association [7]. Unexpectedly, sera were left over from a large number of women, more than enough to investigate in a further case-control design regarding malaria, endemic in Kampala, the capital city of Uganda.

Research topics

  • Cervical Cancer and HPV Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.52768/epidemiolpublichealth/1040

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.